Alan T. Remaley, MD, PhD

2026 Outstanding Contributions to Clinical Chemistry in a Selected Area of Research

Alan T. Remaley, MD, PhD, is the section chief of the lipoprotein metabolism laboratory and a senior staff member of the department of laboratory medicine at the National Institutes of Health. He received a B.S. degree in biochemistry and chemistry (1981) and MD, PhD degrees from the University of Pittsburgh (1987). He completed his clinical [athology residency at the University of Pennsylvania (1990). He has published over 500 papers on lipoprotein metabolism and is an inventor on multiple patents. Dr. Remaley has defined key mechanisms for atheroprotection by High-density lipoproteins, such as by cholesterol efflux via the ABCA1 transporter, developed apoA-I mimetic peptides and recombinant lecithin:cholesterol acyltransferase as investigational therapies, created the widely used Sampson equation for estimating Low-density lipoprotein-cholesterol, and described the first high-resolution cryo-EM structure of APOB100, the main protein component of Low-density lipoproteins.